BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3683431)

  • 1. The cytonucleus test in the rat: a combined metaphase and micronucleus assay.
    Albanese R
    Mutat Res; 1987 Dec; 182(6):309-21. PubMed ID: 3683431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards an improved micronucleus test: studies on 3 model agents, mitomycin C, cyclophosphamide and dimethylbenzanthracene.
    Salamone M; Heddle J; Stuart E; Katz M
    Mutat Res; 1980 Oct; 74(5):347-56. PubMed ID: 6782470
    [No Abstract]   [Full Text] [Related]  

  • 3. Integration of micronucleus tests with a gene mutation assay in F344 gpt delta transgenic rats using benzo[a]pyrene.
    Hori H; Shimoyoshi S; Tanaka Y; Momonami A; Masumura K; Yamada M; Fujii W; Kitagawa Y
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Jan; 837():1-7. PubMed ID: 30595204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous micronucleus and chromosome aberration assessment in the rat.
    Krishna G; Kropko ML; Ciaravino V; Theiss JC
    Mutat Res; 1991 Sep; 264(1):29-35. PubMed ID: 1881414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity test systems for the detection of chromosome aberrations in vivo.
    Matter BE; Tsuchimoto T
    Arch Toxicol; 1980 Nov; 46(1-2):89-98. PubMed ID: 7236000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
    Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
    Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of sixteen carcinogens in the rat using the micronucleus test.
    Trzos RJ; Petzold GL; Brunden MN; Swenberg JA
    Mutat Res; 1978 Sep; 58(1):79-86. PubMed ID: 362195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a twice dosing regimen both before and after partial hepatectomy in the rat liver micronucleus test.
    Itoh S; Igarashi M; Nagata M; Hattori C
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Apr; 782():18-23. PubMed ID: 25868127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of the micronucleus test in the screening and monitoring of mutagens].
    Il'inskikh NN; Il'inskikh IN; Nekrasov VN
    Tsitol Genet; 1988; 22(1):67-72. PubMed ID: 3285552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of micronuclei in incubated hen's eggs as a measure of genotoxicity.
    Wolf T; Luepke NP
    Mutat Res; 1997 Nov; 394(1-3):163-75. PubMed ID: 9434855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic evaluation of etintidine (BL-5641), a novel histamine H2-receptor antagonist, using the chromosome aberration test in CHL cells and the micronucleus test in mice.
    Ishida F; Kamei T
    Mutat Res; 1987 Oct; 180(2):231-7. PubMed ID: 2889140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro micronucleus method with erythropoietin-differentiated erythrocytes.
    Nito S; Kondo Y; Ono T; Ariyuki F
    Mutat Res; 1986 Dec; 175(4):243-7. PubMed ID: 3097534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of micronuclei in metabolically competent rat hepatoma cell lines by the promutagens 7,12-dimethylbenz[a]anthracene, benzo[a]pyrene and cyclophosphamide.
    Tafazoli M; Van Hummelen P; Kiefer F; Kirsch-Volders M
    Mutagenesis; 1995 Jan; 10(1):15-21. PubMed ID: 7739396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vivo/in vitro method for assessing micronucleus and chromosome aberration induction in rat bone marrow and spleen. 1. Studies with cyclophosphamide.
    Moore FR; Urda GA; Krishna G; Theiss JC
    Mutat Res; 1995 Oct; 335(2):191-9. PubMed ID: 7477050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified protocol for the mouse bone marrow micronucleus assay.
    Garriott ML; Piper CE; Kokkino AJ
    J Appl Toxicol; 1988 Apr; 8(2):141-4. PubMed ID: 3132499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An optimal, generalized sampling time of 30 +/- 6 h after double dosing in the mouse peripheral blood micronucleus test.
    Higashikuni N; Sutou S
    Mutagenesis; 1995 Jul; 10(4):313-9. PubMed ID: 7476266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micronucleus test and bone-marrow chromosome analysis: a comparison of 2 methods in vivo for evaluating chemically induced chromosomal alterations.
    Kliesch U; Danford N; Adler ID
    Mutat Res; 1981 Feb; 80(2):321-32. PubMed ID: 7207488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clastogenic effects of five carcinogenic-mutagenic chemicals on the cells of the common carp, Cyprinus carpio L.
    Al-Sabti K
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1986; 85(1):5-9. PubMed ID: 2877805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations into parametric analysis of data from in vivo micronucleus assays by comparison with non-parametric methods.
    Mitchell ID; Brice AJ
    Mutat Res; 1986; 159(1-2):139-46. PubMed ID: 3941664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The micronucleus test with mouse spleen cells.
    Shindo Y; Hirano F; Maeda H; Takeda U
    Mutat Res; 1983 Jul; 121(1):53-7. PubMed ID: 6408474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.